🇺🇸 FDA

Intelligence · Clinical Pipeline

Novo Nordisk A/S Pipeline

All ClinicalTrials.gov programs at Novo Nordisk A/S — phase, modality, and trial IDs.

Programs
40

Quick answer

Novo Nordisk A/S has 40 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ADRENALINE AGUETTANT 1 mg/ml, solution injectable en ampoule

    Novo Nordisk A/S

    Cardiorespiratory arrest at birth in full-term newborns

    phase 3 small molecule active

    1 trial

  2. Cagrilintide

    Novo Nordisk A/S

    Overweight

    phase 3 small molecule completed

    1 trial

  3. Concizumab

    Novo Nordisk A/S

    Haemophilia A Without Inhibitors

    phase 3 small molecule active

    1 trial

  4. Concizumab

    Novo Nordisk A/S

    Haemophilia A With Inhibitors

    phase 3 small molecule active

    1 trial

  5. Faster-acting insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  6. Insulin degludec/insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  7. Insulin icodec

    Novo Nordisk A/S

    Diabetes, Type 2

    phase 3 small molecule completed

    1 trial

  8. NNC0487-0111

    Novo Nordisk A/S

    Obesity

    phase 3 small molecule active

    1 trial

  9. Oral semaglutide

    Novo Nordisk A/S

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  10. Semaglutide

    Novo Nordisk A/S

    Overweight

    phase 3 small molecule completed

    1 trial

  11. Somapacitan

    Novo Nordisk A/S

    Growth Hormone Deficiency in Children

    phase 3 small molecule completed

    2 trials

  12. TEMOZOLOMIDE , KEYTRUDA 25 mg/mL concentrate for solution for infusion, saline solution for infusion

    Novo Nordisk A/S

    Newly diagnosed Glioblastoma

    phase 3 small molecule active

    1 trial

  13. Tecentriq 840 mg concentrate for solution for infusion

    Novo Nordisk A/S

    Metastatic pancreatic ductal adenocarcinoma (mPDAC)

    phase 3 small molecule active

    1 trial

  14. UVEDOSE 100 000 UI, solution buvable en ampoule

    Novo Nordisk A/S

    Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia

    phase 3 small molecule active

    1 trial

  15. Ziltivekimab

    Novo Nordisk A/S

    Heart Failure

    phase 3 small molecule active

    1 trial

  16. biphasic insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  17. eptacog alfa (activated)

    Novo Nordisk A/S

    Acquired Bleeding Disorder

    phase 3 small molecule completed

    1 trial

  18. insulin degludec

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    2 trials

  19. liraglutide

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    2 trials

  20. liraglutide

    Novo Nordisk A/S

    Metabolism and Nutrition Disorder

    phase 3 small molecule completed

    1 trial

  21. nonacog beta pegol

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    phase 3 small molecule completed

    1 trial

  22. rosiglitazone

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule terminated

    1 trial

  23. semaglutide

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    4 trials

  24. somapacitan

    Novo Nordisk A/S

    Growth Hormone Disorder

    phase 3 small molecule completed

    1 trial

  25. turoctocog alfa pegol

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    phase 3 small molecule completed

    2 trials

  26. LY2140023

    Novo Nordisk A/S

    Schizophrenia

    phase 2 small molecule terminated

    1 trial

  27. Matched Placebo

    Novo Nordisk A/S

    Mechanical allodynia

    phase 2 small molecule active

    1 trial

  28. NNC6019-0001

    Novo Nordisk A/S

    Transthyretin Amyloid Cardiomyopathy (ATTR CM)

    phase 2 small molecule completed

    1 trial

  29. Product

    Novo Nordisk A/S

    Women with an indication for IVF/ICSI

    phase 2 small molecule active

    1 trial

  30. activated recombinant human factor VII

    Novo Nordisk A/S

    Acquired Bleeding Disorder

    phase 2 small molecule completed

    2 trials

  31. Faster Aspart

    Novo Nordisk A/S

    Diabetes Mellitus, Type 1

    phase 1 small molecule completed

    1 trial

  32. NNC 0172-0000-2021

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    phase 1 small molecule completed

    1 trial

  33. NNC0480-0389

    Novo Nordisk A/S

    Healthy Volunteers Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  34. To evaluate the pharmacokinetics and safety of nolasiban

    Novo Nordisk A/S

    not applicable (submitted trial is a pharmacokinetic study in healthy subjects)

    phase 1 other active

    1 trial

  35. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial

  36. Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete

    Novo Nordisk A/S

    Hyperlipidaemia

    approved small molecule active

    1 trial

  37. Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete

    Novo Nordisk A/S

    Arterial hypertension

    approved small molecule active

    1 trial

  38. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  39. insulin detemir

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  40. turoctocog alfa

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    approved small molecule completed

    2 trials

Frequently asked questions

How many pipeline programs does Novo Nordisk A/S have?

40 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.